Table Graph
      published meta-analysis   sensitivity analysis   studies

complete primary vaccine series in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias confirmed COVID (any severity)detailed resultsC4591031- first boost, 2021 (REV) 18.52 [7.91; 43.34] 18.52[7.91; 43.34]C4591031- first boost, 2021 (REV)10%10,125NAnot evaluable severe COVID-19 (FDA definition)detailed resultsC4591031- first boost, 2021 (REV) 4.03 [0.18; 89.41] 4.03[0.18; 89.41]C4591031- first boost, 2021 (REV)10%10,125NAnot evaluable severe COVID-19 occurrencedetailed resultsC4591031- first boost, 2021 (REV) 4.03 [0.18; 89.41] 4.03[0.18; 89.41]C4591031- first boost, 2021 (REV)10%10,125NAnot evaluable arrhythmiadetailed resultsC4591031- first boost, 2021 (REV) 0.50 [0.02; 15.01] 0.50[0.02; 15.01]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable hypertensiondetailed resultsC4591031- first boost, 2021 (REV) 2.01 [0.07; 60.05] 2.01[0.07; 60.05]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable Myocardial infarction detailed resultsC4591031- first boost, 2021 (REV) 1.34 [0.30; 6.00] 1.34[0.30; 6.00]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable pulmonary embolismdetailed resultsC4591031- first boost, 2021 (REV) 6.04 [0.30; 120.71] 6.04[0.30; 120.71]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable stroke (non-specific, hemorrhagic, and ischemic)detailed resultsC4591031- first boost, 2021 (REV) 1.01 [0.06; 16.10] 1.01[0.06; 16.10]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable cerebral venous sinus thrombosis (CVST)detailed resultsC4591031- first boost, 2021 (REV) 2.01 [0.07; 60.05] 2.01[0.07; 60.05]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable appendicitisdetailed resultsC4591031- first boost, 2021 (REV) 0.25 [0.01; 5.58] 0.25[0.01; 5.58]C4591031- first boost, 2021 (REV)10%10,075NAnot evaluable0.020.01.0relative treatment effectwww.metaEvidence.org2024-05-09 06:36 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 1317 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons